Skip to content

Stable Angina Management and Treatment

Prospective REgistry of Stable Angina manaGEment and Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03781492
Acronym
PRESAGE
Enrollment
25000
Registered
2018-12-20
Start date
2006-01-01
Completion date
2026-12-31
Last updated
2020-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Stable Angina

Brief summary

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.

Detailed description

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is a single-center, observational study recruiting consecutive patients with stable angina, who were diagnosed and treated in the 3rd Chair and Department of Cardiology in the Silesian Centre for Heart Diseases in Zabrze, Poland. The Silesian Centre for Heart Diseases is a highly specialised cardiology centre with cardiac surgery facilities The main objective of the PRESAGE Registry is to clarify the overall clinical characteristics of patients with stable angina, their demographics and clinical profile, current management, early and long-term outcomes, with regard to the administered treatment. The diagnosis of stable angina was based on clinical characterization, coronary angiography, and the current guidelines of the European Society of Cardiology. Patients with vasospastic and/or microvascular angina were also included to the registry. Performance of coronary angiography is the criterion of the enrolment in the registry. Patients with acute coronary syndromes are excluded from the analysis. Data collection is patient-based (not event-based). Complete patient demographics: medical history, complete hospitalization data (diagnostic and therapeutic) and in-hospital results are collected in an electronic form by the attending physician. The patients are under constant follow-up for all-cause mortality and major cardiac adverse events.

Interventions

None listed

Sponsors

Silesian Centre for Heart Diseases
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* symptom based diagnosis of stable angina

Exclusion criteria

* acute coronary syndrome on admission * ≤ 18 years old

Design outcomes

Primary

MeasureTime frame
Number of participants with reported deaths from any causeFrom date of inclusion until the date of death from any cause, assessed up to 5 year

Secondary

MeasureTime frame
Number of participants with reported myocardial infarctionFrom date of inclusion until the date of first event, assessed up to 5 year
Number of participants with reported cerebrovascular insultFrom date of inclusion until the date of first event, assessed up to 5 year
Number of participants with reported acute coronary syndrome driven revascularisationFrom date of inclusion until the date of first event, assessed up to 5 year

Countries

Poland

Contacts

Primary ContactPiotr Desperak, MD
desperak.piotr@gmail.com+48514374167

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026